Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Mark W Kieran
Affiliation
Boston Children's Hospital and Harvard Medical School
ORCID
Career Start Year
1982
Papers
270
H Index
76
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37969032
The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.
Am J Med Genet A
2024
37969032
The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy.
Am J Med Genet A
2024
36780194
ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.
Clin Cancer Res
2023
36780194
ALK Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma.
Clin Cancer Res
2023
36919608
Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.
Circulation
2023
37493630
Predictive value of micro-RNA expression profiling in pediatric desmoid fibromatosis.
Acta Oncol
2023
37493630
Predictive value of micro-RNA expression profiling in pediatric desmoid fibromatosis.
Acta Oncol
2023
36919608
Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation.
Circulation
2023
35105861
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.
Nat Commun
2022
35947814
The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions.
J Clin Oncol
2022
35624227
Notch signaling in malignant gliomas: supporting tumor growth and the vascular environment.
Cancer Metastasis Rev
2022
35552452
Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry.
Neuro Oncol
2022
35788723
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.
Nat Cancer
2022
35918506
An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry.
J Neurooncol
2022
36479060
Diagnostics and prospective outcome of a diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters after surgical resection (DGONC): a case report.
Neurooncol Adv
2022
35290915
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
Eur J Cancer
2022
35121998
The current landscape of immunotherapy for pediatric brain tumors.
Nat Cancer
2022
35105861
PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation.
Nat Commun
2022
35788723
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma.
Nat Cancer
2022
35624227
Notch signaling in malignant gliomas: supporting tumor growth and the vascular environment.
Cancer Metastasis Rev
2022
35552452
Characteristics of children ⿤36 months of age with DIPG: A report from the international DIPG registry.
Neuro Oncol
2022
36479060
Diagnostics and prospective outcome of a diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters after surgical resection (DGONC): a case report.
Neurooncol Adv
2022
35947814
The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions.
J Clin Oncol
2022
35918506
An international study evaluating the epidemiology of intracranial germ cell tumors in the native versus immigrant Japanese populations: the need for an international registry.
J Neurooncol
2022
35290915
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
Eur J Cancer
2022
35121998
The current landscape of immunotherapy for pediatric brain tumors.
Nat Cancer
2022
33336845
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Pediatr Blood Cancer
2021
33860611
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence.
Pediatr Blood Cancer
2021
33585982
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
Acta Neuropathol
2021
33735109
The progeria research foundation 10<sup>th</sup> international scientific workshop; researching possibilities, ExTENding lives - webinar version scientific summary.
Aging (Albany NY)
2021
33601323
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.
Eur J Cancer
2021
33140540
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
Pediatr Blood Cancer
2021
33336845
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Pediatr Blood Cancer
2021
33601323
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.
Eur J Cancer
2021
33735109
The progeria research foundation 10<sup>th</sup> international scientific workshop; researching possibilities, ExTENding lives - webinar version scientific summary.
Aging (Albany NY)
2021
33585982
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
Acta Neuropathol
2021
33860611
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence.
Pediatr Blood Cancer
2021
33140540
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
Pediatr Blood Cancer
2021
31233466
Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma.
J Pediatr Hematol Oncol
2020
32236425
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.
Neuro Oncol
2020
31986450
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Eur J Cancer
2020
32381545
MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.
AJNR Am J Neuroradiol
2020
32992153
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
2020
32801214
Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.
Proc Natl Acad Sci U S A
2020
32688206
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
2020
32558190
Pediatric cancer research: Surviving COVID-19.
Pediatr Blood Cancer
2020
31233466
Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma.
J Pediatr Hematol Oncol
2020
31292757
Sixty years single institutional experience with pediatric craniopharyngioma: between the past and the future.
Childs Nerv Syst
2020
31986450
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Eur J Cancer
2020
32688206
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
2020
1 - 50 of 540
Column Actions
Search
Recommended Authors
Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year
2016
Number of shared co-authors
40
Juan C Vasquez
Yale School of Medicine
Career Start Year
2015
Number of shared co-authors
1
Diana S Osorio
Nationwide Children's Hospital and The Ohio State University
Career Start Year
2013
Number of shared co-authors
19
Holly Lindsay
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year
2012
Number of shared co-authors
44
Prajwal Rajappa
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year
2011
Number of shared co-authors
2
Bhuvana A Setty
Ohio State University College of Medicine/Nationwide Children's Hospital
Career Start Year
2011
Number of shared co-authors
6
Xin Wang
The Chinese University of Hong Kong, Prince of Wales Hospital
Career Start Year
2010
Number of shared co-authors
66
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year
2008
Number of shared co-authors
82
Patricia Baxter
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year
2008
Number of shared co-authors
38
Cassie Kline
Children's Hospital of Philadelphia
Career Start Year
2008
Number of shared co-authors
37
Matthew D Wood
Oregon Health & Science University
Career Start Year
2007
Number of shared co-authors
30
Sonia Partap
Stanford University
Career Start Year
2006
Number of shared co-authors
58
Muh-Lii Liang
MacKay Memorial Hospital
Career Start Year
2003
Number of shared co-authors
16
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year
2002
Number of shared co-authors
20
Noah Federman
University of California los angeles
Career Start Year
2001
Number of shared co-authors
10
Sheila K Singh
McMaster University
Career Start Year
2001
Number of shared co-authors
28
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
73
Shahrad Rod Rassekh
British Columbia Children's Hospital, The University of British Columbia
Career Start Year
1998
Number of shared co-authors
13
Scott C Borinstein
Vanderbilt University Medical Center
Career Start Year
1998
Number of shared co-authors
8
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
8
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year
1995
Number of shared co-authors
21
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1994
Number of shared co-authors
41
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year
1990
Number of shared co-authors
53
Howard A Fine
Meyer Cancer Center
Career Start Year
1990
Number of shared co-authors
20
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1988
Number of shared co-authors
70
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year
1986
Number of shared co-authors
17
David M Loeb
Children's Hospital at Montefiore.
Career Start Year
1986
Number of shared co-authors
17
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year
1978
Number of shared co-authors
24
Corey Raffel
University of California San Francisco
Career Start Year
1974
Number of shared co-authors
15
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year
1974
Number of shared co-authors
27
row(s) 1 - 30 of 30
Collaborators
Liliana C Goumnerova
Co-authored papers
43
Keith L Ligon
Co-authored papers
31
Roger J Packer
Brain Tumor Institute, Children's National Hospital
Co-authored papers
28
Stewart Goldman
Co-authored papers
25
Pratiti Bandopadhayay
Co-authored papers
23
Robert M Scott
Co-authored papers
21
Peter E Manley
Co-authored papers
20
Tina Young Poussaint
Co-authored papers
17
Rameen Beroukhim
Co-authored papers
17
Scott L Pomeroy
Harvard Medical School
Co-authored papers
15
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
15
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
13
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
13
Charles D Stiles
Co-authored papers
11
Ian F Pollack
University of Pittsburgh School of Medicine
Co-authored papers
11
Sandro Santagata
Co-authored papers
11
Eric Bouffet
The Hospital for Sick Children
Co-authored papers
11
Patrick Y Wen
Co-authored papers
10
Darren Hargrave
Co-authored papers
10
Guillaume Bergthold
Co-authored papers
10
Nicholas K Foreman
Co-authored papers
9
Kenneth J Cohen
Co-authored papers
9
Peter C Phillips
Co-authored papers
9
Donna Neuberg
Co-authored papers
9
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
8
Azra H Ligon
Co-authored papers
8
Hayley Malkin
Co-authored papers
8
Daniel C Bowers
University of Texas Southwestern Medical School
Co-authored papers
8
Uri Tabori
Co-authored papers
8
Lori A Ramkissoon
Co-authored papers
8
1 - 30